Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H)

被引:45
作者
Hirst, C.
Raasch, S.
Llewelyn, G.
Robertson, N.
机构
[1] Univ Hosp Wales, Helen Durham Neuro Inflammatory Ctr, Dept Neurol, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Hosp Wales, Dept Clin Neurophysiol, Cardiff CF14 4XN, S Glam, Wales
关键词
D O I
10.1136/jnnp.2005.076869
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:800 / 802
页数:3
相关论文
共 7 条
[1]   Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation [J].
Avivi, I ;
Chakrabarti, S ;
Kottaridis, P ;
Kyriaku, C ;
Dogan, A ;
Milligan, DW ;
Linch, D ;
Goldstone, AH ;
Mackinnon, S .
BONE MARROW TRANSPLANTATION, 2004, 34 (02) :137-142
[2]   Rituximab-responsive CIDP [J].
Briani, C ;
Zara, G ;
Zambello, R ;
Trentin, L ;
Rana, M ;
Zaja, F .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (11) :788-788
[3]  
Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO
[4]  
2-#
[5]  
Hughes RA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003280
[6]   RESHAPING HUMAN-ANTIBODIES FOR THERAPY [J].
RIECHMANN, L ;
CLARK, M ;
WALDMANN, H ;
WINTER, G .
NATURE, 1988, 332 (6162) :323-327
[7]   INCREASED FREQUENCIES OF HPRT MUTANT T-LYMPHOCYTES IN PATIENTS WITH GUILLAIN-BARRE-SYNDROME AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY - FURTHER EVIDENCE FOR A ROLE OF T-CELLS IN THE ETIOPATHOGENESIS OF PERIPHERAL DEMYELINATING DISEASES [J].
VANDENBERG, LH ;
MOLLEE, I ;
WOKKE, JHJ ;
LOGTENBERG, T .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (01) :37-42